What is low testosterone? The clinical definition most men (and many doctors) get wrong

Low testosterone, clinically called male hypogonadism, is a syndrome defined by persistent symptoms plus biochemical evidence of testosterone deficiency, usually supported by morning total testosterone below 350 ng/dL or free testosterone below 100 pg/mL when symptoms persist. A lab number alone is not a diagnosis, and symptoms alone are not enough either. That dual requirement is the part many direct to consumer clinics, and many conventional practices, still get wrong.

Key takeaways

• Male hypogonadism requires both persistent symptoms and biochemical evidence of testosterone deficiency. A low lab value alone does not establish the diagnosis, and symptoms alone are not enough either.^{[1] [2] [3]}
• The AUA uses total testosterone below 300 ng/dL as a diagnostic cutoff, while EAU guidance uses about 12 nmol/L, roughly 350 ng/dL, as a practical decision threshold and emphasizes symptoms and clinical context, creating an important gray zone between 300 and 350 ng/dL.
• Testosterone shows diurnal variation and meaningful within person variability, so proper testing should use morning samples, ideally from 07:00 to 11:00.^{[5] [6]}
• Only about 2 to 3 percent of circulating testosterone is free, while 40 to 60 percent is tightly bound to SHBG, so a man can have normal total testosterone and still have testosterone deficiency if free testosterone is low.^{[7] [8] [11]}
• LH and FSH are mandatory because high LH with low testosterone indicates primary hypogonadism, while low or normal LH with low testosterone indicates secondary hypogonadism and a different treatment path.^{[1] [2]}
• At Veedma, symptomatic men are assessed against decision thresholds of 350 ng/dL for total testosterone and 100 pg/mL for free testosterone, with direct free testosterone measurement by equilibrium dialysis with LC-MS/MS.

What low testosterone actually means

Low testosterone means male hypogonadism, a clinical syndrome defined by persistent symptoms plus biochemical evidence of testosterone deficiency.^{[1] [2] [3]}

Hypogonadism means the body is not getting enough effective testosterone signaling to maintain normal male function.

Biochemical evidence means blood test confirmation collected under proper conditions, not a guess based on symptoms alone.

According to the AUA guideline, the diagnosis starts with symptoms or signs that fit testosterone deficiency and then requires low testosterone on laboratory testing.^[1] The same principle runs through major endocrine guidance. Testosterone deficiency is not defined by a spreadsheet value in isolation.^[2]

This is where clinical practice often splits in the wrong direction. Some direct to consumer clinics treat a number, even when symptom burden is unclear. Some traditional clinicians do the opposite and dismiss classic symptoms because the result sits somewhere inside a broad lab range. Both errors miss the low T definition itself.

In practical terms, the syndrome usually includes persistent sexual, physical, or neurobehavioral changes such as reduced libido, erectile dysfunction, fewer morning erections, fatigue, reduced strength, or low mood. Those symptoms still need laboratory confirmation before the label of male hypogonadism is justified.^{[3] [10]}

Why persistent symptoms matter

Late onset hypogonadism must include persistent symptoms and biochemical evidence, not a temporary dip after a bad night, acute illness, or short term stress.^{[1] [3] [5] [6]}

Late onset hypogonadism means adult onset testosterone deficiency that develops gradually over time.

In the European Male Ageing Study, men most likely to have true late onset hypogonadism were identified by a pattern of specific symptoms plus low testosterone, not by nonspecific fatigue alone.^[3]

The word “persistent” matters because testosterone is biologically variable. A man recovering from infection, sleeping poorly, or under unusual physiologic stress may show a temporary low result that does not represent his baseline. A valid diagnosis requires a repeated pattern, not a single bad day.

Why guidelines disagree on the low T definition

The low T definition differs by guideline because expert groups rely on different datasets and put different weight on fixed thresholds versus the broader syndrome.^{[1] [2] [10]}

According to the AUA guideline, low testosterone is defined biochemically as total testosterone below 300 ng/dL, about 10.4 nmol/L, in a symptomatic man.^[1] EAU guidance uses about 12 nmol/L, roughly 350 ng/dL, as a practical decision threshold while still emphasizing that the diagnosis is syndrome based rather than purely numeric. Neither approach is “wrong.” The AUA is more threshold driven. The EAU is more syndrome driven.

The gray zone between 300 and 350

The gray zone between 300 and 350 ng/dL is where many men with real testosterone deficiency are told they are “normal.”

A man at 280 ng/dL is low by both frameworks. A man at 320 ng/dL is above the AUA cutoff but still below the EAU decision threshold. If he also has persistent low libido, erectile dysfunction, reduced morning erections, fatigue, and low free testosterone, the clinical picture can still support male hypogonadism.^{[1] [3] [10] [11]}

Late onset hypogonadism is best understood as a clinicobiochemical syndrome, not a border dispute around one number.^[10] That is why a rigid cutoff can underdiagnose some symptomatic men, while overdiagnosing others who simply happen to sit below a threshold without a compatible symptom pattern.

At Veedma, this gray zone is handled by interpreting symptoms, morning sampling conditions, direct free testosterone, LH, and FSH together. Symptomatic men are assessed against decision thresholds of 350 ng/dL for total testosterone and 100 pg/mL for free testosterone, because the goal is to identify clinically meaningful testosterone deficiency, not just a low looking number.

Why there is no single “normal” testosterone number

Normal testosterone levels in men are statistical ranges, not fixed physiologic truths that apply equally to every man.^{[4] [5] [6]}

A reference range tells you where a population falls. It does not tell you whether a given man has enough effective androgen activity for his own tissues, his SHBG level, or his symptom threshold.

Biological variation is real

Testosterone changes within the same man from day to day and even hour to hour. Diurnal variation makes morning concentrations higher on average than later values, especially in younger men, which is why proper testing is done in the morning.^[5]

Intraindividual variation adds more noise. Brambilla and colleagues showed that repeated measurements in the same man can vary enough to change interpretation if testing conditions are not standardized.^[6] Sleep restriction, acute illness, stress, and short term changes in health status can all suppress testosterone temporarily.

That is why the clinically useful question is not “What was my testosterone once?” but “What is my repeated morning testosterone pattern when I am well?” For a step by step protocol, see the complete low testosterone testing guide.

Lab methods and reference ranges also shift the answer

Lab method can materially change the reported testosterone result.^[7]

An Endocrine Society position statement notes that immunoassays and mass spectrometry do not perform equally, especially at lower concentrations and for free testosterone, which is one reason apparently conflicting results are common across laboratories.^[7]

Population reference ranges introduce another problem. Many commonly used ranges were derived from heterogeneous groups that included older men and men with obesity, metabolic disease, or other unrecognized conditions that depress testosterone. A 2017 harmonization study improved standardization, but a harmonized range is still a population description rather than a personalized clinical target.^{[4] [10]}

This is why a test can come back “normal” even when the man does not feel normal. For that scenario in detail, see why your testosterone test came back “normal” and why that might be wrong.

At Veedma, the initial evaluation includes more than 40 biomarkers, with ongoing monitoring twice per year and morning sampling from 07:00 to 11:00, because a single total testosterone value does not classify testosterone deficiency. If you already have outside results, including comprehensive panels from services such as Function Health, they can be reviewed in context rather than read as isolated numbers.

Why free testosterone changes the picture

Free testosterone often explains symptoms when total testosterone looks acceptable on paper.^{[7] [8] [11]}

Free testosterone is the small fraction of testosterone that circulates unbound and is immediately available to tissues.

Bioavailable testosterone means free testosterone plus the albumin bound fraction that can readily dissociate and enter tissues.

SHBG, short for sex hormone binding globulin, is a liver made protein that binds testosterone tightly and reduces the fraction available to tissues.

Only about 2 to 3 percent of circulating testosterone is free. About 40 to 60 percent is tightly bound to SHBG, and another 38 to 40 percent is loosely bound to albumin.^{[7] [8]}

This matters because a man can have total testosterone that looks “normal” but still have testosterone deficiency if SHBG is high and free testosterone is low. Antonio and colleagues reported that low free testosterone was associated with hypogonadal signs and symptoms even in men whose total testosterone remained within the reference range.^[11]

Why two men with the same total testosterone can feel different

Two men with the same total testosterone can have different symptom burdens because free testosterone availability and tissue responsiveness are not identical.^{[9] [11]}

SHBG levels rise with aging, liver disease, hyperthyroidism, and some medications, which can reduce biologically active testosterone even when total testosterone looks acceptable.^{[7] [10]}

Variation in androgen receptor sensitivity may also contribute, although it is not part of routine clinical evaluation.^[9] This helps explain why some men are more symptomatic than others at similar circulating testosterone levels.

Calculated free testosterone versus direct measurement

Calculated free testosterone is usually more informative than total testosterone alone when SHBG is likely to distort the picture.^[8]

The traditional approach uses the Vermeulen formula with total testosterone, SHBG, and albumin. That approach is often more useful than total testosterone alone when direct free testosterone measurement is unavailable.^[8]

Equilibrium dialysis is the gold standard for direct free testosterone measurement, but it is rarely used in routine clinical practice.^[7]

At Veedma, free testosterone is measured directly by equilibrium dialysis with LC-MS/MS rather than estimated from a separate SHBG test. This is why hidden testosterone deficiency is less likely to be missed than in a basic panel built around total testosterone alone.

Why LH and FSH are mandatory in the diagnosis

LH and FSH are mandatory because low testosterone cannot be classified correctly without knowing whether the testes are failing or the brain is under signaling.^{[1] [2]}

LH and FSH are pituitary hormones that tell the testes to make testosterone and sperm.

The three origins of hypogonadism

Male hypogonadism is clinically classified as primary, secondary, or functional. Rare androgen resistance disorders are separate conditions that can mimic low androgen effect despite normal or even high testosterone.

Primary hypogonadism means the testes are the main problem. The typical pattern is low testosterone with high LH, and often high FSH, because the brain is signaling harder but the testes are not responding adequately.^{[1] [2] [10]}

Secondary hypogonadism means the signaling problem is central. The typical pattern is low testosterone with low or inappropriately normal LH and FSH, which shows that the testes may still be capable of responding if stimulation is restored.^{[1] [2]}

Functional hypogonadism means the hypothalamic pituitary testicular axis is being suppressed by potentially reversible factors such as obesity, systemic illness, medications, sleep disruption, or other physiologic stressors. The biochemical pattern is often low testosterone with low or inappropriately normal LH and FSH, but the cause is not fixed testicular failure.

Why classification changes treatment

Where the problem originates determines whether a man needs replacement therapy or may be able to restore his own production with stimulation therapy.

High LH with low testosterone points to primary hypogonadism, where testosterone replacement is usually required because the testes cannot respond adequately. In symptomatic men with secondary or functional hypogonadism and LH below 8 mIU/mL, Enclomiphene is the preferred first line option because the axis may still be intact and endogenous production may be restimulated, while TRT is generally reserved for primary hypogonadism or for men who do not respond adequately. Without LH and FSH, the clinician is guessing.^{[1] [2]}

This is the most important branch point in the workup, and it is why Veedma checks LH and FSH alongside total and free testosterone in every diagnostic evaluation. For a fuller explanation, see Primary vs secondary hypogonadism: Where the problem starts and why it changes everything.

What testosterone deficiency can affect throughout the body

Testosterone deficiency is systemic because testosterone helps regulate muscle, bone, fat distribution, red blood cell production, mood, cognition, cardiovascular health, and metabolic function.^{[2] [10]}

Testosterone supports maintenance of lean mass and bone mineral density, influences where fat is stored, stimulates erythropoiesis, and contributes to sexual function, motivation, and aspects of cognitive performance.^[2]

When testosterone signaling is chronically inadequate, the effects can extend well beyond sex drive. Men may see loss of muscle, rising central fat, lower exercise tolerance, lower hemoglobin, impaired sexual function, poorer mood, and reduced overall quality of life.^[10]

According to major clinical guidelines and reviews, this is why male hypogonadism should be approached as a multisystem disorder rather than a cosmetic issue or a normal part of getting older.^{[2] [10]}

Myth vs fact

Myth: Low testosterone is just a lab number

Fact: Male hypogonadism requires both persistent symptoms and biochemical evidence of testosterone deficiency. A low number without symptoms does not establish the syndrome, and symptoms without lab confirmation are not enough either.^{[1] [2] [3]}

Myth: Any result above 300 ng/dL means low T is impossible

Fact: The AUA cutoff is below 300 ng/dL, but EAU guidance uses about 12 nmol/L, roughly 350 ng/dL, as a practical decision threshold and emphasizes symptom context. Men in the 300 to 350 ng/dL range can still fit the clinical picture of testosterone deficiency, especially if free testosterone is low.^{[1] [10] [11]}

Myth: Normal total testosterone rules out hypogonadism

Fact: Only a small fraction of testosterone is free. If SHBG is high, total testosterone can appear normal while free testosterone is low and symptoms persist.^{[7] [8] [11]}

Myth: LH and FSH are optional add on tests

Fact: LH and FSH are essential because they show whether low testosterone is primary or secondary. That distinction determines whether a man is more likely to need testosterone replacement or to respond to fertility preserving stimulation therapy such as Enclomiphene.^{[1] [2]}

Myth: Low testosterone is just normal aging

Fact: Late onset hypogonadism requires persistent symptoms plus biochemical evidence of deficiency. Broad age related reference ranges can hide clinically important testosterone deficiency, and temporary dips from illness or poor sleep do not count as a diagnosis.^{[3] [5] [6] [10]}

Bottom line

Low testosterone is not defined by one lab value. It is male hypogonadism, a clinical syndrome diagnosed only when persistent symptoms match biochemical evidence, ideally with properly collected morning total and free testosterone plus mandatory LH and FSH to classify the cause. For the full diagnostic and treatment roadmap, see the Low testosterone hub.

References

1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. The Journal of urology. 2018;200:423-432. PMID: 29601923
2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018;103:1715-1744. PMID: 29562364
3. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. The New England journal of medicine. 2010;363:123-35. PMID: 20554979
4. Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. The Journal of clinical endocrinology and metabolism. 2017;102:1161-1173. PMID: 28324103
5. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clinical endocrinology. 2003;58:710-717. PubMed
6. Brambilla DJ, O’Donnell AB, Matsumoto AM, McKinlay JB. Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clinical endocrinology. 2007;67:853-862. PubMed
7. Rosner W, Auchus RJ, Azziz R, et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. The Journal of clinical endocrinology and metabolism. 2007;92:405-13. PMID: 17090633
8. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of clinical endocrinology and metabolism. 1999;84:3666-72. PMID: 10523012
9. Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness. International journal of andrology. 2003;26:76-83. PubMed
10. European Association of Urology. EAU Guidelines on Sexual and Reproductive Health. Chapter: Male hypogonadism. EAU guideline chapter
11. Antonio L, Wu FC, O’Neill TW, et al. Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone. The Journal of clinical endocrinology and metabolism. 2016;101:2647-57. PMID: 26909800